140 related articles for article (PubMed ID: 7929408)
21. Sequence of human eosinophil-derived neurotoxin cDNA: identity of deduced amino acid sequence with human nonsecretory ribonucleases.
Hamann KJ; Barker RL; Loegering DA; Pease LR; Gleich GJ
Gene; 1989 Nov; 83(1):161-7. PubMed ID: 2591744
[TBL] [Abstract][Full Text] [Related]
22. Hyperglycosylation of eosinophil ribonucleases in a promyelocytic leukemia cell line and in differentiated peripheral blood progenitor cells.
Tiffany HL; Li F; Rosenberg HF
J Leukoc Biol; 1995 Jul; 58(1):49-54. PubMed ID: 7616105
[TBL] [Abstract][Full Text] [Related]
23. Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease.
Gleich GJ; Loegering DA; Bell MP; Checkel JL; Ackerman SJ; McKean DJ
Proc Natl Acad Sci U S A; 1986 May; 83(10):3146-50. PubMed ID: 3458170
[TBL] [Abstract][Full Text] [Related]
24. Enhanced expression of the eosinophil-derived neurotoxin ribonuclease (RNS2) gene requires interaction between the promoter and intron.
Tiffany HL; Handen JS; Rosenberg HF
J Biol Chem; 1996 May; 271(21):12387-93. PubMed ID: 8647842
[TBL] [Abstract][Full Text] [Related]
25. The molecular biology of eosinophil granule proteins.
Hamann KJ; Barker RL; Ten RM; Gleich GJ
Int Arch Allergy Appl Immunol; 1991; 94(1-4):202-9. PubMed ID: 1657792
[TBL] [Abstract][Full Text] [Related]
26. Eosinophil-derived neurotoxin and human liver ribonuclease. Identity of structure and linkage of neurotoxicity to nuclease activity.
Sorrentino S; Glitz DG; Hamann KJ; Loegering DA; Checkel JL; Gleich GJ
J Biol Chem; 1992 Jul; 267(21):14859-65. PubMed ID: 1634526
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic ribonuclease chimeras. Targeted tumoricidal activity in vitro and in vivo.
Newton DL; Ilercil O; Laske DW; Oldfield E; Rybak SM; Youle RJ
J Biol Chem; 1992 Sep; 267(27):19572-8. PubMed ID: 1527074
[TBL] [Abstract][Full Text] [Related]
28. Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus.
Domachowske JB; Dyer KD; Bonville CA; Rosenberg HF
J Infect Dis; 1998 Jun; 177(6):1458-64. PubMed ID: 9607820
[TBL] [Abstract][Full Text] [Related]
29. Characterization of eosinophils generated in vitro from CD34+ peripheral blood progenitor cells.
Rosenberg HF; Dyer KD; Li F
Exp Hematol; 1996 Jul; 24(8):888-93. PubMed ID: 8690047
[TBL] [Abstract][Full Text] [Related]
30. [Biochemistry and biological activities of eosinophil granule proteins].
Enokihara H; Koike T
Nihon Rinsho; 1993 Mar; 51(3):605-12. PubMed ID: 7684096
[TBL] [Abstract][Full Text] [Related]
31. Evolution of antiviral activity in the ribonuclease A gene superfamily: evidence for a specific interaction between eosinophil-derived neurotoxin (EDN/RNase 2) and respiratory syncytial virus.
Domachowske JB; Bonville CA; Dyer KD; Rosenberg HF
Nucleic Acids Res; 1998 Dec; 26(23):5327-32. PubMed ID: 9826755
[TBL] [Abstract][Full Text] [Related]
32. Localization of eosinophil-derived neurotoxin and eosinophil cationic protein in neutrophilic leukocytes.
Sur S; Glitz DG; Kita H; Kujawa SM; Peterson EA; Weiler DA; Kephart GM; Wagner JM; George TJ; Gleich GJ; Leiferman KM
J Leukoc Biol; 1998 Jun; 63(6):715-22. PubMed ID: 9620664
[TBL] [Abstract][Full Text] [Related]
33. Cytokine induction of granule protein synthesis in an eosinophil-inducible human myeloid cell line, AML14.
Paul CC; Ackerman SJ; Mahrer S; Tolbert M; Dvorak AM; Baumann MA
J Leukoc Biol; 1994 Jul; 56(1):74-9. PubMed ID: 8027673
[TBL] [Abstract][Full Text] [Related]
34. Eosinophils, ribonucleases and host defense: solving the puzzle.
Rosenberg HF; Domachowske JB
Immunol Res; 1999; 20(3):261-74. PubMed ID: 10741866
[TBL] [Abstract][Full Text] [Related]
35. Eosinophil granule proteins in peripheral blood granulocytes.
Abu-Ghazaleh RI; Dunnette SL; Loegering DA; Checkel JL; Kita H; Thomas LL; Gleich GJ
J Leukoc Biol; 1992 Dec; 52(6):611-8. PubMed ID: 1464733
[TBL] [Abstract][Full Text] [Related]
36. Construction, expression and characterization of chimaeric toxins containing the ribonucleolytic toxin restrictocin: intracellular mechanism of action.
Rathore D; Batra JK
Biochem J; 1997 Jun; 324 ( Pt 3)(Pt 3):815-22. PubMed ID: 9210405
[TBL] [Abstract][Full Text] [Related]
37. Atomic resolution (0.98 A) structure of eosinophil-derived neurotoxin.
Swaminathan GJ; Holloway DE; Veluraja K; Acharya KR
Biochemistry; 2002 Mar; 41(10):3341-52. PubMed ID: 11876642
[TBL] [Abstract][Full Text] [Related]
38. Intronic enhancer activity of the eosinophil-derived neurotoxin (RNS2) and eosinophil cationic protein (RNS3) genes is mediated by an NFAT-1 consensus binding sequence.
Handen JS; Rosenberg HF
J Biol Chem; 1997 Jan; 272(3):1665-9. PubMed ID: 8999843
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions.
Hatzelmann A; Tenor H; Schudt C
Br J Pharmacol; 1995 Feb; 114(4):821-31. PubMed ID: 7539697
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms involved in activation of human eosinophil exocytosis by substance P: an in vitro model of sensory neuroimmunomodulation.
el-Shazly AE; Masuyama K; Ishikawa T
Immunol Invest; 1997; 26(5-7):615-29. PubMed ID: 9399104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
